Our phenotypic findings align with several studies that have demonstrated a role for TCF-1 in supporting memory cell capacity and countering terminal effector differentiation and exhaustion programs in mice with acute and chronic viral infections, in human chronic hepatitis C infection, and in mouse and human cancers (31, 32, 36–38, 41, 44, 61–65). Here, TCF7 is linked to viral infectious disease.